Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportMolecular Targeting Probes-Radioactive & Nonradioactive - Infection and Inflammation in Probe Development

Novel PET Probe for Imaging-Based Differentiation of Foreign-Body-Associated Bacterial Infection from Sterile Inflammation.

Mukesh Pandey, Aditya Bansal, Shalini Sharma, Viktoria Krol, Val Lowe, Mark Nathan, Stephen Broski, Robin Patel and Daniel Berry
Journal of Nuclear Medicine June 2024, 65 (supplement 2) 242297;
Mukesh Pandey
1Mayo Clinic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aditya Bansal
1Mayo Clinic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shalini Sharma
1Mayo Clinic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Viktoria Krol
1Mayo Clinic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Val Lowe
2Mayo Clinic Rochester MN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark Nathan
1Mayo Clinic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephen Broski
1Mayo Clinic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robin Patel
1Mayo Clinic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel Berry
1Mayo Clinic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Abstract

242297

Introduction: There has been a significant rise in surgical procedures involving implantation of prosthetic devices with a consequent increase in the number of associated infections. The incidence of infection in orthopedic trauma patients is high, depending upon type of injury, location, and severity of trauma. Other surgical procedures like implantation of cardiac devices, instrumented spinal fusions, and vascular grafts can also be associated with serious microbial infections. However, after invasive surgical procedures, it can be difficult to differentiate between inflammation and infection, which is needed to define ideal treatment. Diagnosis of bacterial infection can be challenging, especially in the early stage and deep-seated infections. Thus, there is a clinical need for reliable, sensitive, and specific noninvasive imaging to identify bacterial infection and differentiate it from inflammation. Herein, we developed a novel small molecule-based PET imaging probe, [68Ga]Ga-BP, and evaluated it in foreign body methicillin-resistant Staphylococcus aureus (MRSA) osteomyelitis, in comparison with inflamed and normal rat models and also compared results to those with [68Ga]Ga-Citrate and [18F]FDG.

Methods: Synthesis of [68Ga]Ga-BP was carried out with >98% radiochemical purity with a final pH of 6.0-6.5 before injection. MRSA foreign body osteomyelitis was generated in Wistar rats, with uninfected instrumented animals used for comparison. At day 7 post-surgery, the diet of the rats was switched from normal chow diet to an iron-deficient diet and deionized water for the ensuing 7 days. On day 14 post-surgery, the rats fasted for 6 h before administration of [68Ga]Ga-BP. On the day of imaging, [68Ga]Ga-BP (35.11±3.59 MBq, n = 5), [68Ga]Ga-citrate (26.32±7.99 MBq, n = 4) and [18F]FDG (40.35±2.97MBq, n = 4) were injected into the tail vein of normal, MRSA and instrumented non-infected groups of Wistar rats with foreign body. After administration of the radiotracers, all animals underwent a 10 min static PET scan at 15, 30, 60, and 120 min post-injection (p.i) followed by 7 min CT scan using Siemens Inveon PET/CT scanner. Acquired images were analyzed using MIM 7.2.7 software. After final imaging, animals were euthanized, and vital organs/tissues and infected tibia harvested for ex vivo biodistribution. The extent of infection in terms of CFU/g was calculated from harvested vital organs and infected tibiae.

Results: The MRSA infected foreign body osteomyelitis model had ~1.3E+07 CFU MRSA/g (mean) in infected tibia with no bacteria isolated from the liver, kidney, urine, or blood. Imaging showed >10-fold higher uptake in infected tibiae than contralateral tibiae at 120 min post injection (Figure 1A-B). The higher uptake of [68Ga]Ga-BP in infected tibiae appeared as early as 15 min p.i. and increased over time. In addition, [68Ga]Ga-BP differentiated between the inflammation and bacterial infection (Figure 1C-D). Comparing uptake of [68Ga]Ga-BP, in normal, instrumented uninfected; and infected tibiae, there was a significant difference in uptake of [68Ga]Ga-BP between instrumented uninfected and infected tibiae. Comparison of [68Ga]Ga-BP with [68Ga]Ga-citrate and [18F]FDG showed superiority of [68Ga]Ga-BP in identifying the site of bacterial infection.

Conclusions: The developed novel PET probe, [68Ga]Ga-BP, showed superior imaging capability to identify MRSA-infected tibiae as compared to [68Ga]Ga-citrate or [18F]FDG, offering potential clinical and commercial value in diagnosing the bacterial infection and differentiating it from sterile inflammation. Acknowledgment: We thank the Division of Nuclear Medicine at Mayo Clinic, National Center for Advancing Translational Sciences of NIH grants UL1TR002494/UL1TR002377, and Minnesota Partnership for Biotechnology and Medical Genomics Translational Product Development Fund for funding this study. There is a pending patent application on this technology.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 65, Issue supplement 2
June 1, 2024
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Novel PET Probe for Imaging-Based Differentiation of Foreign-Body-Associated Bacterial Infection from Sterile Inflammation.
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Novel PET Probe for Imaging-Based Differentiation of Foreign-Body-Associated Bacterial Infection from Sterile Inflammation.
Mukesh Pandey, Aditya Bansal, Shalini Sharma, Viktoria Krol, Val Lowe, Mark Nathan, Stephen Broski, Robin Patel, Daniel Berry
Journal of Nuclear Medicine Jun 2024, 65 (supplement 2) 242297;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Novel PET Probe for Imaging-Based Differentiation of Foreign-Body-Associated Bacterial Infection from Sterile Inflammation.
Mukesh Pandey, Aditya Bansal, Shalini Sharma, Viktoria Krol, Val Lowe, Mark Nathan, Stephen Broski, Robin Patel, Daniel Berry
Journal of Nuclear Medicine Jun 2024, 65 (supplement 2) 242297;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • The study of multi-targets PET tracer on early monitoring ICI curative effect of lung cancer
  • Noninvasive monitoring of mesenchymal stem cell, dasatinib and quercetin combination therapy with [18F]FDG PET in venous neointimal hyperplasia associated with Arteriovenous fistula
Show more Molecular Targeting Probes-Radioactive & Nonradioactive - Infection and Inflammation in Probe Development

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire